Abstract
A vastarray of bioactive peptides from amphibian skin secretions is attracting increasing attention due to the growing problem of bacteria resistant to conventional antibiotics. In this report, a small molecular antibacterial peptide, named Xenopus laevis antibacterial peptide-P1 (XLAsp-P1), was isolated from the skin of Xenopus laevis using reversed-phase high-performance liquid chromatography. The primary structure of XLAsp-P1, which has been proved to be a novel peptide by BLAST search in AMP database, was DEDDD with a molecular weight of 607.7 Da analysed by Edman degradation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/TOF–MS). The highlight of XLAsp-P1 is the strong in vitro potency against a variety of Gram-positive and Gram-negative bacteria with minimum inhibitory concentrations (MICs) starting at 10 μg/mL and potent inhibitory activity against breast cancer cell at tested concentrations from 5 to 50 μg/mL. In addition, only 6.2 % of red blood cells was haemolytic when incubated with 64 μg/mL (higher than MICs of all bacterial strain) of XLAsp-P1. The antimicrobial mechanism for this novel peptide was the destruction of the cell membrane investigated by transmission electron microscopy. All these showed that XLAsp-P1 is a novel short anionic antibacterial peptide with broad antibacterial activity and inhibitory activity against breast cancer cell.
Similar content being viewed by others
References
Badosa E, Ferre R, Planas M (2007) A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Peptides 28:2276–2285
Balakrishna A, Kumar MH (2015) Evaluation of synergetic anticancer activity of berberine and curcumin on different models of A549, Hep-G2, MCF-7, Jurkat, and K562 cell lines. BioMed Res Int 2015:1636–1642
Bevins CL, Zasloff M (1990) Peptides from frog skin. Annu Rev Biochem 59:395–414
Bignami GS (1993) A rapid and sensitive hemolysis neutralization assay for palytoxin. Toxicon 1993(31):817–820
Boman HG (1991) Antibacterial peptides: key components needed in immunity. Cell 65:205–207
Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238–250
Brown KL, Hancock REW (2006) Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 18:24–30
Chan WC, White PD (2000) Fmoc solid phase peptide synthesis: a practical approach. Oxford University Press, Oxford
Che Q (2008) A novel antimicrobial peptide from amphibian skin secretions of Odorrana grahami. Peptides 29:529–535
Chen J-Y, Lin W-J, Lin T-L (2009) A fish antimicrobial peptide, tilapia hepcidin TH2-3, shows potent antitumor activity against human fibrosarcoma cells. Peptides 30:1636–1642
Conlon JM, Kolodziejek J, Nowotny N (2004) Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochim Biophys Acta 1696:1–14
Conlon JM, Woodhams DC, Raza H, Coquet L, Leprince J, Jouenne T et al (2007) Peptides with differential cytolytic activity from skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae). Toxicon 50:498–506
Conlon JM, Mechkarska M, Lukic ML, Flatt PR (2014) Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents. Peptides 57:67–77
Cruz-Chamorro L, Puertollano MA, Puertollano E (2006) In vitro biological activities of magainin alone or in combination with nisin. Peptides 27:1201–1209
Eley A (2008) Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria. Peptides 29:25–30
Erspamer V, Bertaccini G, De Caro G, Endean R, Impicciatore M (1967) Pharmacological actions of caerulein. Experientia 23:702–703
Erspamer V, Melchiorri P, Falconieri Erspamer G, Montecucchi PC, de Castiglione R (1985) Phyllomedusa skin: a huge factory and store-house of a variety of active peptides. Peptides 3:7–12
Fjell CD, Hiss JA, Hancock RE, Schneider G (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11:37–51
Hou F, Li J et al (2011) Isolation and characterisation of a new antimicrobial peptide from the skin of Xenopus laevis. Int J Antimicrob Agents 38:510–515
Kikuchi K, Bernard EM, Sadownik A (1997) Antimicrobial activities of squalamine mimics. Antimicrob Agents Chemother 41(7):1433–1438
Lazarus LH, Attila M (1993) The toad, ugly and venomous, wears yet a precious jewel in his skin. Prog Neurobiol 41:473–507
Marr AK, Gooderham WJ, Hancock RE (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6:468–472
Matsuzaki K (1998) Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta 1376:391–400
Mechkarska M, Attoub S, Sulaiman S (2014) Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa. Regul Pept 194–195:69–76
Mensa B, Howell GL (2014) Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16. Antimicrob Agents Chemother 58(9):5136–5145
Midura-Nowaczek K, Markowska A (2014) Antimicrobial Peptides and their analogs: searching for new potential therapeutics. Perspect Medicin Chem 6:73–80
Roseghini M, Falconieri Erspamer G, Severini C, Simmaco M (1989) Biogenic amines and active peptides in extracts of the skin of thirty-two European amphibian species. Comp Biochem Physiol C 94:455–460
Simmaco M, Mignogna G, Barra D (1998) Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers 47:435–450
Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S (2007) A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea. Peptides 28:1331–1343
Tyler MJ, Stone DJ, Bowie JH (1992) A novel method for the release and collection of dermal, glandular secretions from the skin of frogs. J Pharmacol Toxicol Methods 28:199–200
Zasloff M (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84:5449–5453
Zhou J, McClean S (2006) Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri. Peptides 27:3077–3084
Acknowledgments
This work was supported by the Project of National Key Technology Research and Development Program for the 12th Five-year Plan (No. 2013BAD16B09) and by the Project of Changchun Science and Technology Plans (No. 2013187).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All applicable international, national and/or institutional guidelines for the care and use of animals were followed.
Additional information
Communicated by Erko Stackebrandt.
Siming Li and Linlin Hao have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, S., Hao, L., Bao, W. et al. A novel short anionic antibacterial peptide isolated from the skin of Xenopus laevis with broad antibacterial activity and inhibitory activity against breast cancer cell. Arch Microbiol 198, 473–482 (2016). https://doi.org/10.1007/s00203-016-1206-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00203-016-1206-8